PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Miyakis S et al. – The data suggest that voriconazole TDM is appropriate for all patients as soon as steady state is achieved. For non–responding patients with low trough concentrations, the association with IFI–related mortality indicates the need for dose adjustments to achieve and sustain voriconazole concentrations.

Related Articles

Human Dectin-1 Deficiency and Mucocutaneous Fungal Infections
New England Journal of Medicine, 10/29/09    Relevance Score: 70%

Genetic variability of innate immunity impacts human susceptibility to fungal diseases
International Journal of Infectious Diseases, 11/03/09    Relevance Score: 68%

A Homozygous CARD9 Mutation in a Family with Susceptibility to Fungal Infections
New England Journal of Medicine, 10/29/09    Relevance Score: 68%

The current role of amphotericin B lipid complex in managing systemic fungal infections
Current Medical Research and Opinion, 10/26/09    Relevance Score: 68%

Hyperbaric oxygen therapy as an anti-infective agent
Expert Review of Anti-infective Therapy, 10/21/09    Relevance Score: 68%

Today in Infectious Disease...keeping you current

Post-infectious new daily persistent headache may respond to intravenous methylprednisolone
The Journal of Headache and Pain, 11/25/09

Chronic Obstructive Pulmonary Disease: Role of Bacteria and Updated Guide to Antibacterial Selection in the Older Patient
Drugs & Aging, 11/25/09

Emergency Influenza Drug
JAMA, 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address